Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2013-10-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease
NCT04891107
The Effects of a Single Session of Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients
NCT05973565
Treadmill and Music Cueing for Gait Training in Mild to Moderate Parkinson's Disease
NCT00750945
Sing for Your Saunter - Dementia Supplement
NCT04518917
Amped-PD: Amplifying Physical Activity Through Music in Parkinson Disease
NCT05421624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MCW
Music Contingent Walking (MCW) group: study-specific musical device that measures gait and plays music in a portable manner as the participant is walking is set at a threshold individually calculated per participant, and the music will stop playing when walking strides fall below this threshold.
Exercise
Walking and other forms of exercise have been seen clinically and in numerous research studies to be effective against Parkinson's symptoms.
Music
NCMW
Non-contingent Music Walking (NCMW) group: music on all the time regardless of the stride size.
Exercise
Walking and other forms of exercise have been seen clinically and in numerous research studies to be effective against Parkinson's symptoms.
Music
NMW
Non-music walking (NMW/silent) group: no music on at all regardless of step size.
Exercise
Walking and other forms of exercise have been seen clinically and in numerous research studies to be effective against Parkinson's symptoms.
MCW+rasagiline
Music contingent walking with rasagiline group: same paradigm as the previous MCW, but with rasagiline prescribed as adjunct therapy.
Dosage: 0.5 mg/day for the first 2 weeks to be subsequently increased to 1 mg/day
Azilect
Rasagiline is Parkinson's medication that can be taken alone early in the disease or with other medication and is hypothesized to produce synergistic effects with exercise.
Exercise
Walking and other forms of exercise have been seen clinically and in numerous research studies to be effective against Parkinson's symptoms.
Music
MMW+rasagiline
Non-music (silent) walking with rasagiline group: same paradigm as the previous NMW, but with rasagiline prescribed as adjunct therapy.
Dosage: 0.5 mg/day for the first 2 weeks to be subsequently increased to 1 mg/day
Azilect
Rasagiline is Parkinson's medication that can be taken alone early in the disease or with other medication and is hypothesized to produce synergistic effects with exercise.
Exercise
Walking and other forms of exercise have been seen clinically and in numerous research studies to be effective against Parkinson's symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Azilect
Rasagiline is Parkinson's medication that can be taken alone early in the disease or with other medication and is hypothesized to produce synergistic effects with exercise.
Exercise
Walking and other forms of exercise have been seen clinically and in numerous research studies to be effective against Parkinson's symptoms.
Music
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed diagnosis of Parkinson's Disease
* Can walk 5 to 10 minutes unassisted
* Have a safe place to walk (outdoor or indoor)
* Have mild to moderate Parkinson's disease (HY1-3)
* Be able to lay flat in the scanner for the period of the study
* No reliance on wheelchair or other walking aid for ambulation
* Absence of any other serious medical conditions such as hearing impairment and dementia
* No history of other neurological and psychiatric illnesses
* No recent musculoskeletal impairment or injuries that may prevent walking
Exclusion Criteria
* Unconfirmed PD diagnosis
* Require walking aid, wheelchair-bound
* No access to safe walking pathway
* Severe PD (Hoehn \& Yahr stages\>3)
* Impaired hearing
* Atypical Parkinsonism
* Concurrent dementia
* Recent knee, hip or foot injury (need permission from doctor)
* Pacemaker
* Brain aneurysm clip
* Cochlear implant
* Recent surgery within the past 6 weeks
* Possibility of pregnancy
* Electrical stimulator for nerves or bones
* Implanted infusion pump
* History of any eye injury involving metal fragments
* History of working with metals (grinding, machining, or welding)
* Artificial heart valve
* Orthopaedic hardware (artificial joint, plate, screws, rods)
* Other metallic prostheses
* Coil, catheter or filter in any blood vessel
* Ear or eye implant
* Recent tattoos within the past 6 weeks
* Shrapnel, bullets, or other metallic fragments
* Medication releasing skin patches (nicotine, birth control, nitroglycerine)
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin J McKeown, MD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Silke Cresswell, MD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pacific Parkinson's Research Centre
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H13-02074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.